SCN8A and Dravet syndrome: Furthermore, it was recently shown that antisense oligonucleotide treatment to decrease Scn8a (Nav1.6) expression was sufficient to rescue disease phenotypes in a Dravet Syndrome model of Scn1a haploinsufficiency [52].